| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004514359 |
| P356 | DOI | 10.1186/1479-5876-10-159 |
| P932 | PMC publication ID | 3476974 |
| P698 | PubMed publication ID | 22871104 |
| P5875 | ResearchGate publication ID | 230631678 |
| P50 | author | Nestor F Gonzalez-Cadavid | Q92730697 |
| Dolores Vernet | Q122228091 | ||
| P2093 | author name string | Gaby Nolazco | |
| George E Kopchok | |||
| Istvan Kovanecz | |||
| Judy Sc Wang | |||
| Rodney A White | |||
| Sheryl L Chow | |||
| P2860 | cites work | The regenerative potential of angiotensin AT2 receptor in cardiac repair. | Q37988002 |
| The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes | Q38483509 | ||
| Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats | Q38498729 | ||
| Notch2 negatively regulates myofibroblastic differentiation of myoblasts | Q40219754 | ||
| Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil | Q41822316 | ||
| Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. | Q42094814 | ||
| cGMP modulates stem cells differentiation to neurons in brain in vivo | Q43230613 | ||
| Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. | Q43706400 | ||
| Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice | Q44935527 | ||
| Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice | Q44970917 | ||
| Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. | Q46025702 | ||
| Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. | Q46600601 | ||
| In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect | Q46689741 | ||
| Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. | Q46738229 | ||
| The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size | Q46785598 | ||
| Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells | Q46892052 | ||
| PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation | Q46927614 | ||
| Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection | Q46987652 | ||
| Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. | Q46991340 | ||
| Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction | Q48252402 | ||
| Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes | Q60758048 | ||
| Differential myocardial infarct repair with muscle stem cells compared to myoblasts | Q81123128 | ||
| A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts | Q81469764 | ||
| Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique | Q81932797 | ||
| Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium | Q27301781 | ||
| Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts | Q30480210 | ||
| Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status | Q34124779 | ||
| Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy | Q34208448 | ||
| Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide | Q34503391 | ||
| Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits | Q34543457 | ||
| Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor. | Q34793299 | ||
| Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction | Q35037360 | ||
| Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway | Q35056906 | ||
| Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism | Q35174777 | ||
| Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. | Q35500693 | ||
| Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. | Q35553198 | ||
| Differential expression of PDE5 in failing and nonfailing human myocardium | Q35680934 | ||
| Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle | Q35789114 | ||
| Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase | Q36357896 | ||
| Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle. | Q36998190 | ||
| Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. | Q36999849 | ||
| ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. | Q37200237 | ||
| Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium | Q37286527 | ||
| Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus | Q37306331 | ||
| Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1 | Q37310691 | ||
| The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. | Q37366776 | ||
| Mechanisms of penile fibrosis | Q37408368 | ||
| Novel pharmacotherapies to abrogate postinfarction ventricular remodeling | Q37437162 | ||
| Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications | Q37450782 | ||
| Cardiac fibroblasts: at the heart of myocardial remodeling | Q37491524 | ||
| Erectile dysfunction following prostatectomy: prevention and treatment | Q37573390 | ||
| Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy | Q37704966 | ||
| Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology | Q37744271 | ||
| Stem cell therapy for chronic myocardial infarction | Q37766194 | ||
| Regulation and dysregulation of fibrosis in skeletal muscle | Q37767061 | ||
| Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. | Q37771768 | ||
| Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities | Q37771886 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 159 | |
| P577 | publication date | 2012-08-07 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Effects of sildenafil and/or muscle derived stem cells on myocardial infarction | |
| P478 | volume | 10 |
| Q90344621 | Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture |
| Q37353891 | Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction |
| Q36951110 | Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu |
| Q90056593 | Microenergy acoustic pulses induced myogenesis of urethral striated muscle stem/progenitor cells |
| Q37646812 | Muscle Derived Stem Cells Stimulate Muscle Myofiber Repair and Counteract Fat Infiltration in a Diabetic Mouse Model of Critical Limb Ischemia. |
| Q36998190 | Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle. |
| Q41600750 | Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. |
| Q35116422 | The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets |
Search more.